Status:
UNKNOWN
LIWA for Treatment of Alzheimer Patients
Lead Sponsor:
American Society Of Thermalism And Climatology Inc
Conditions:
Alzheimer Disease
Eligibility:
All Genders
50-80 years
Phase:
PHASE1
PHASE2
Brief Summary
The thermal therapy combined with magnetic fields and ozone has a direct effect on patients with dementia and Alzheimer's with a regression of more than 60% of them
Detailed Description
Alzheimer's disease (AD) is the leading cause of dementia and cognitive deteriorating in the advanced age. This main target of this study is to determine the safety and efficacy of transcranial magnet...
Eligibility Criteria
Inclusion
- Men and women aged 50-85.
- Diagnosed with Alzheimer's disease for at least half a year (by the DSM-IV criteria).
- Scored 16-26 on the MMSE.
- Received drug therapy for their disease, with each treatment having been administered at an acceptable dosage for at least 5 weeks.
- Existence of a routine therapist for changes or adverse effects reports.
- Existence of Alzheimer diagnosis by CT or MRI tests.
- Answered in the negative to all questions in the pre-TMS treatment safety questionnaire.
- Gave their oral and written consent to participate in the trial.
Exclusion
- An additional neurological disorder.
- Severe psychiatric disorder.
- Uncontrolled hypertension, beyond 170/110.
- History of epilepsy, seizure, or heat convulsion or History of epilepsy or seizure in first degree relatives.
- History of head injury or stroke.
- History of metal implants in the head (except dental fillings)or History of surgery entailing metallic implants or known history of any metallic particles in the eye, implanted cardiac pacemaker, cochlear implants, use of neuro stimulators, or any medical pumps.
- History of migraines in the last six months.
- History of drug or alcohol abuse.
- Inadequate communication with examiner.
- Participation in another clinical study, either concurrent with this trial or in the 3 months preceding it.
- Inability to sign a consent form.
- Leukemia
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02204969
Start Date
January 1 2015
End Date
December 1 2015
Last Update
January 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaviota Clinic
Newark, New Jersey, United States, 07105